Mayank Jain

Mayank Jain

Active Director Director DIN 07993851
DIN 07993851 First appointment Feb 2020 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 5 active board seats
Past companies 1 historical roles
Total affiliations 6 Since Feb 2020
Shareholding value •••• Premium profile

About Mayank Jain

Data last updated:

Mayank Jain is a Director at Brawn Laboratories Limited (since 2024), Director at Brawn Biotech Limited (since 2024) and Director at Am2pm Support Private Limited (since 2022), and holds 2 more current directorships. The companies operate in Pharma, Information Technology and Business Services. The 4 current companies with reported revenue have a combined latest revenue of ₹384 Cr; the largest is Brawn Laboratories Limited at ₹369 Cr (FY 2025). Earlier, Mayank Jain was an Additional Director at Go Value Financial Services Private Limited (2022–2025).

DIN 07993851
Primary Designation Director
Industry Pharma
First Appointment 13 Feb 2020
Oldest Company Age 41 yrs
Largest company Brawn Laboratories Limited · ₹369 Cr (FY 2025)
Combined revenue ₹384 Cr across 4 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Brawn Laboratories Limited U73200DL1990PLC039653
Director28 Aug 20241990₹369 Cr (FY 2025)Active
Brawn Biotech Limited L74899DL1985PLC022468
Director27 Aug 20241985₹13.56 Cr (FY 2025)Active
Am2pm Support Private Limited U74999DL2021PTC380529
Director02 May 20222021₹1.63 Cr (FY 2025)Active
Consult Avenue Private Limited U74999DL2020PTC361843
Director13 Feb 20202020₹1.4 Lakh (FY 2025)Active
Equisavvy Support Private Limited U70200DL2023PTC415326
Director06 Jun 20232023Under Process Of Striking Off

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Additional Director19 Sep 20222022₹4,049 (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Consult Avenue Private Limited
Am2pm Support Private Limited
Brawn Laboratories Limited
Brawn Biotech Limited
Premium access

Shareholding and investment profile for Mayank Jain

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mayank Jain

Mayank Jain currently holds 5 directorships: Brawn Laboratories Limited (Director, since 28 Aug 2024, revenue ₹369 Cr (FY 2025)); Brawn Biotech Limited (Director, since 27 Aug 2024, revenue ₹13.56 Cr (FY 2025)); Am2pm Support Private Limited (Director, since 02 May 2022, revenue ₹1.63 Cr (FY 2025)); Consult Avenue Private Limited (Director, since 13 Feb 2020, revenue ₹1.4 Lakh (FY 2025)); Equisavvy Support Private Limited (Director, since 06 Jun 2023).

Mayank Jain was first appointed on 13 Feb 2020 as Director at Consult Avenue Private Limited. The most recent appointment on record is 28 Aug 2024 at Brawn Laboratories Limited.

The 4 current companies of Mayank Jain that report revenue have a combined latest revenue of ₹384 Cr: Brawn Laboratories Limited ₹369 Cr (FY 2025); Brawn Biotech Limited ₹13.56 Cr (FY 2025); Am2pm Support Private Limited ₹1.63 Cr (FY 2025); Consult Avenue Private Limited ₹1.4 Lakh (FY 2025).

Mayank Jain held 1 earlier board appointment: Go Value Financial Services Private Limited (Additional Director, 19 Sep 2022 to 21 Feb 2025).

The current boards of Mayank Jain's companies include Ankit Goyal (Brawn Laboratories Limited), Brij Raj Gupta (Brawn Laboratories Limited), Pooja Jha (Brawn Laboratories Limited), Priyanka Sharma (Brawn Biotech Limited), Rati Garg (Brawn Biotech Limited), Ankit Kapoor (Am2pm Support Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available